March 1, 2022 – To meet the growing industry demand for highly trained clinical professionals specializing in cardiac rhythm management and electrophysiology, Harding University has created the first Master of Science in Cardiac Function and Interventional Technology (CFIT) degree program in the nation.

March 1, 2022 – The larger the sail, the more wind it catches. But as that size increases, so does the stress experienced by each sheet and line connected to the canvas.

March 1, 2022 – Patients with both a high lipoprotein(a) and high coronary artery calcium score (CAC) face a more than 20% risk of heart attack or stroke over the following 10 years, according to findings from a multi-center study led by preventive cardiologists at UT Southwestern Medical Center.

March 1, 2022 – A new report says the wearable healthcare devices market is anticipated to grow at a CAGR of 13% from $16 billion in 2021 to $61 billion by 2032.

March 1, 2022 – Scientists have known for years that a person’s risk of cardiovascular disease (CVD) can be lowered with lifestyle changes such as modifying diet, exercise, alcohol and tobacco use.

February 28, 2022 – iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the advancement of cardiac care, announced that the results of the KP-Rhythm2 study, titled “Diagnostic yield

February 28, 2022 – InspireMD, Inc., a global developer of the CGuard Embolic Prevention Stent System (EPS) device for the treatment of carotid artery disease and stroke prevention, today announced its CGuard Carotid Stent, utilizing its proprietary MicroNet mesh, will be included as a device option for stenting in the CREST-2 Trial.

February 28, 2022 – Boston Scientific Corporation has announced positive results from a new analysis assessing real-world outcomes with the WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device.

February 28, 2022  – The normal functioning of human body requires a steady flow of energy. This energy in the form of adenosine triphosphate (ATP) is produced by breaking down carbon sources like glucose, lipids, or amino acids. The tricarboxylic acid (TCA) cycle, one of the most important ATP-producing processes in the mitochondria, is a major hub of metabolites and is known for ensuring a fine balance between its cyclic intermediates, referred to as the 'metabolic flux.'

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now